Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells
- 23 May 2002
- journal article
- Published by Springer Nature in Oncogene
- Vol. 21 (23), 3727-3738
- https://doi.org/10.1038/sj.onc.1205474
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 40 references indexed in Scilit:
- Selective Growth-Inhibitory, Cell-Cycle Deregulatory and Apoptotic Response of Apigenin in Normal versus Human Prostate Carcinoma CellsBiochemical and Biophysical Research Communications, 2001
- Involvement of retinoblastoma (Rb) and E2F transcription factors during photodynamic therapy of human epidermoid carcinoma cells A431Oncogene, 1999
- Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumorsCancer, 1998
- Nuclear Factor Kappa B: Important Transcription Factor and Therapeutic TargetThe Journal of Clinical Pharmacology, 1998
- Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistanceCurrent Opinion in Oncology, 1995
- Apigenin and tangeretin enhance gap junctional intercellular communication in rat liver epithelial cellsCarcinogenesis: Integrative Cancer Research, 1994
- Bcl-2 functions in an antioxidant pathway to prevent apoptosisCell, 1993
- Genotoxicities of nitropyrenes and their modulation by apigenin, tannic acid, ellagic acid and indole-3-carbinol in the Salmonella and CHO systemsMutation Research, 1992
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987
- The pharmacology of airway hyper-reactivityTrends in Pharmacological Sciences, 1984